YARW

Yarrow Bioscience Inc. Common Stock (YARW)

Stock · NASDAQ · Health Care

$18.36as of 10/16/2026

Active signals

Resistance level
$18.51
Industry
Biotechnology: Pharmaceutical Preparations

What YARW's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakdown22-2.6%50%
Bollinger Band Breakout21+1.8%57%
Volume Spike8-0.6%50%
200-Day Moving Average TouchActive now6+4.0%67%
Any 20-session window (baseline)-2.1%45%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About YARW

Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
7

Fundamentals

1-day range
$18.05$20.1
Market cap
$116.71M
P/E (trailing)
—
P/E (forward)
-11.10
EPS (trailing)
$-21.85
Dividend yield
—
Beta
—
Avg. volume
92.5K
Ex-dividend date
July 24, 2026
Dividend pay date
July 23, 2026
52-week range
$18.16$44.28

Forecasts

2 analyst ratings

Buy 89%
Hold 11%
Sell 0%
1-year price forecast
High
$58
+215.9%
Median
$57
+210.5%
Low
$56
+205.0%

Yarrow Bioscience Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • YARW
    Yarrow Bioscience Inc. Common Stock
    $18.31
    ▼ 8.45%
    Market cap $116.71MP/E —
    $18.16$44.28
  • ANIX
    Anixa Biosciences Inc. Common Stock
    $2.67
    ▼ 3.96%
    Market cap $116.70MP/E —
    $2.32$5.46
  • CPIX
    Cumberland Pharmaceuticals Inc. Common Stock
    $7.18
    ▼ 4.77%
    Market cap $115.07MP/E —
    $1.85$9.28
  • BGM
    BGM Group Ltd. Class A Ordinary Shares
    $8.65
    ▲ 0.70%
    Market cap $118.62MP/E —
    $6.45$303
  • PMN
    ProMIS Neurosciences Inc. Common Shares (ON)
    $8.15
    ▼ 6.32%
    Market cap $119.54MP/E —
    $6.27$27.4
  • CUE
    Cue Biopharma Inc. Common Stock
    $16.71
    ▼ 10.50%
    Market cap $113.45MP/E —
    $4.97$45.5
  • GNLX
    Genelux Corporation Common Stock
    $2.42
    ▼ 2.42%
    Market cap $121.07MP/E —
    $2.29$8.54

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
201.2K
Disposed
294.6K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.